Table 1 Clinicopathologic characteristics of cohort.
Case | Age/sex | Site | Morphology | CD34 | Desmin | Target RNA sequencing (Archer) | FISH | Follow-up (months) |
---|---|---|---|---|---|---|---|---|
1 | 4/F | Hip | Maturing | P | N | No fusion identified | NP | AWOD; 78 |
2 | 4/M | Neck | Maturing | P | Fo | CHCHD7-PLAG1 | NP | NA |
3 | 4/M | Leg | Maturing | P | Fo | CHCHD7-PLAG1 | NP | AWOD; 28 |
4 | 6/M | Calf | Maturing | P | P | CHCHD7-PLAG1 | NP | AWOD; 2 |
5 | 6/M | Arm | Maturing | P | N | HNRNPC-PLAG1a, CHCHD7-PLAG1 | NP | AWOD; 25 |
6 | 6/F | Leg | Maturing | P | N | CHCHD7-PLAG1 | NP | AWOD; 1 |
7 | 10/F | Neck | Maturing | P | P | COL3A1-PLAG1a, CHCHD7-PLAG1 | NP | AWOD; 1 |
8 | 11/F | Pretibial | Maturing | P | N | No fusion identified | NP | NA |
9 | 18/M | Palm | Maturing | P | N | No fusion identified | NP | AWOD; 107 |
10 | 19/M | Back | Maturing | P | N | No fusion identified | NP | NA |
11 | 29/M | Neck | Maturing | P | N | No fusion identified | NP | NA |
12 | 31/M | Palm | Maturing | NP | NP | No fusion identified | NP | AWOD; 54 |
13 | 31/M | Thigh | Maturing | P | P | No fusion identifiedb | N | NA |
14 | 44/F | Thigh | Maturing | P | P | SRSF3-PLAG1 | NP | AWOD; 1 |
15 | 4/F | Neck | Fibroblastic | P | Fo | PCMTD1-PLAG1 | NP | AWOD; 17 |
16 | 7/M | Back | Fibroblastic | P | Fo | YWHAZ-PLAG1 | NP | NA |
17 | 10/M | Back | Fibroblastic | P | P | CTDSP2-PLAG1 | N | NA |
18 | 10/F | Arm | Fibroblastic | P | P | PPP2R2A-PLAG1b | N | AWOD; 5 |
19 | 16/M | Hand | Fibroblastic | P | P | No fusion identifiedb, c | P | NA |
20 | 7/M | Ankle | Conventional | P | N | No fusion identified | NP | AWOD; 29 |
21 | 13/M | Arm | Conventional | P | Fo | CHCHD7-PLAG1b | N | NA |
22 | 41/F | Foot | Conventional | P | N | No fusion identified | NP | NA |